Lilly Rallies The Troops: Price Controls Would Trigger “Death Spiral”

Any erosion of free pricing or intellectual property protections in the U.S. pharmaceutical market would lead to a new wave of consolidation in the industry, Lilly CEO Sidney Taurel told the American Enterprise Institute March 18 in Washington, D.C